ABSTRACT To study the putative agent(s) related to Crohn disease, we intraperitoneally injected mesenteric Iyph node homogenates from four patients with active Crohn disease into 10-week-old athymic (nu/nu) mice. Control mice (nu/nu) were injected with homogenates of mesenteric lymph nodes from two patients with ulcerative colitis and four patients undergoing elective cholecystectomy, and with a homogenate of a cervical lymph node containing sarcoid granuloma. Thirty-four mice received filtered or unfiltered homogenates from Crohn disease lymph nodes. Thirty-two mice received homogenates or filtrates from lymph nodes of control patients. Four mice from the group injected with Crohn disease homogenates from four different patients developed generalized lymphadenopathy due to lymphoma 10-28 weeks after the injection. Two additional mice developed lymphadenopathy due to plasma cell hyperplasia.
None of the control mice developed lymphomas or lymphadenopathy. Two lymphomas were fiomogenized, filtered, and injected intraperitoneally into a second group of nu/nu mice, which also developed Iymphoma within 8 weeks of injection. Two lymphomas were cultured in vitro and B cell surface markers were identified. Indirect immunofluorescence studies in two lymphomas showed cytoplasmic staining of lymphoma cells with sera from 10 patients with active Crohn disease but not with sera from 13 control subjects, including 6 with ulcerative colitis and 7 with other gastrointestinal disorders. These results suggest that a transmissible factor present in Crohn disease lymph nodes produces lymphoma in nu/nu mice. Furthermore, sera of Crohn disease patients contain an antibody that recognizes an "antigen(s)" in the murine lymphoma. Crohn disease is a common chronic inflammatory bowel disease of the small and large intestine; its etiology is unknown. There is no specific medical therapy, and surgical resection of the diseased segment is commonly followed by recurrence. The nature of the anatomic lesions and the clinical course of disease suggest an infectious etiology. A variety of infectious agents, including viruses, L-forms of bacteria, and mycobacteria have been inconsistently isolated from tissues of patients with Crohn disease (1) (2) (3) (4) (5) (6) (7) (8) (9) .
The disease does not occur spontaneously in animals. Injection of mice and rabbits with homogenates of diseased intestine and lymph nodes from patients with Crohn disease produced granukomas in the intestine and at the injection sites. The lesions occurred several months after injection.
Uniqueness of athymic T cell-deficient (nu/nu) mice for the study of various infectious agents, including parasites, bacteria, and viruses, and of various neoplastic agents has been demonstrated (10) (11) (12) (13) (14) (15) (16) (17) (18) . For example, Epstein-Barr virus, influenza virus, Pneumocystis carinii, Listeria monocytogenes, and Mycobactersum leprae could not be grown by conventional techniques but were identified after injection in nu/nu mice (10-14, 16, 19-21) . Therefore, we used nude mice (nu/nu) in a search for a disease-specific transmissible agent of Crohn disease. Cryostat sections were incubated with these sera (diluted 1:2 and 1:4) followed by incubation with FITC-conjugated antirabbit F(ab')2 fragments.
MATERIALS AND METHODS

Nude
Immunofluorescent Studies with the Lymphoid Cell Lines. Approximately 106 lymphoid cells were washed twice in Pi/ NaCl/5% bovine serum albumin and 0.1% sodium azide and centrifuged at 675.6 X g for 10 vertical illuminator HB 200-W mercury lamp, FITC, KP-600 exciter filters, FL-400 reflector, and 50 barrier filter were used for FITC staining. Photographs were taken with Kodak Ektachrome ASA 400 film. RESULTS Table 1 summarizes the clinicopathologic findings in 66 animals injected with lymph node homogenates obtained from four patients with active Crohn disease who underwent intestinal resections, four individuals who had cholecystectomy, two patients with active ulcerative colitis who required total colectomy, and one patient with sarcoidosis.
Morbidity of nu/nu mice was generally low except among the animals injected with either Crohn disease material or filtrates of a lymph node from a patient with sarcoid granuloma. Autopsy examination was possible only in 5 of the 15 mice that died unexpectedly during the initial few months after injection. No obvious cause of death was found in them.
Six nu/nu mice that received Crohn disease homogenates from four different Crohn disease patients developed clinically significant lymphadenopathy (Fig. 1) . In four animals, lymphadenopathy was associated with splenomegaly and was due to diffuse lymphocytic lymphoma (Fig. 2) . In two other animals, lymphadenopathy was due to benign reactive changes characterized by pronounced plasma cell proliferation with no obliteration of normal architecture or invasion of surrounding tissues. Injection of homogenates from each of the four patients with Crohn disease resulted in the development of lymphoma in one of the injected animals. Two lymphoma-bearing animals received unfiltered lymph node homogenates and developed lymphomas 12 and 16 weeks after injection. The other two animals received filtered homogenates and developed the tumor 22 and 28 weeks after injection.
To investigate the presence of a possible tumor-associated transmissible agent, two of the tumors were homogenized and cell-free supernatants were injected into a group of five nu/nu mice (two with one tumor homogenate and three with the other). Three of these animals died within four days after injection. The remaining two injected with two tumor filtrates developed lymphomas 8 and 10 weeks after the injection. In each case tumor growth was predominantly intraabdominal. These tumors were histologically similar to those from which the extracts were prepared.
nu/nu mice that were injected with homogenates of lymph nodes obtained from two patients with ulcerative colitis, one patient with sarcoidosis, or four with cholecystitis did not develop lymphoma during the subsequent 12 months (Table 1) . Additional control mice consisted of 10 hepatitis, lymphocytic choreomeningitis, ectromelia, and lactic dehydrogenase virus. Screening was performed by using the mouse antibody production test in which tumor tissue is injected into mice and development of specific viral antibodies is examined immunologically. The same tumor was also examined by Microbiological Associates for mycoplasma by using the Hoechst stain. Each of these studies gave negative results. Table 2 summarizes the surface markers of the two lymphoma cell lines being maintained for 12 and 8 months. Both lymphoid cell lines showed surface fluorescence when stained with polyvalent anti-mouse immunoglobulins. To confirm that the fluorescence staining with anti-Ig was not due to Fc receptors on cell membranes, F(ab')2 antisera were used; the results were similar to those with intact antibody. Seventy to 80% of both lymphoid cell lines were positive for Fc receptors and negative for complement receptors as tested by rosetting techniques. Immunofluorescent staining for-a T cell specific marker, Thy-1.2 antigen, was negative. These results indicate that the lymphomas are of murine B cell origin.
All Crohn disease sera obtained from ten additional patients in 1:4 and 1:8 dilutions showed intense fluorescence (++ to +++) when incubated with sections of lymph node tumor.
Two patterns were observed: (i) uniform cytoplasmic staining with intense fluorescence of lymphoid cells present in clusters (Fig. 3B) , and (fi) scattered intracytoplasmic dense staining in speckles or "inclusions."
Sera from the control subjects including six patients with ulcerative colitis, two with nonspecific diarrhea, and five normal subjects did not show any such fluorescence (Fig. 3A and Table 3 ). Sera of neither Crohn disease nor control patients showed any staining when incubated with a normal lymph node from a nu/nu mouse or lymph nodes obtained from the mice injected with material from non-Crohn disease patients. In (1) (2) (3) (4) (5) (6) (7) (8) (9) . After injection of homogenates of intestine or lymph node from Crohn disease patients into normal mice, a granulomatous reaction occurred at the injection site and in the intestine in 3-17 months. Both local and systemic granulomata developed in normal and thymectomized CBA mice after repeated inocculation with Crohn tissue (4). Several laboratories described a virus (30-90 nm) in tissue culture monolayers that were inoculated with filtrates of Crohn tissue homogenates (5) (6) (7) (8) ). An RNA virus was suggested because growth was not inhibited by 5-iodo-2'-deoxyuridine (6) .
In other laboratories, cell wall-deficient bacterial variants like those of Pseudomonas group Va have been found in the small intestine and in mesenteric nodes from some patients with Crohn disease but not in any patients with ulcerative colitis (9) .
It is unclear whether virus or cell wall-deficient bacterial variants are etiologic agents in Crohn disease or whether they preferentially invade tissues affected by this disease. The organisms that have been isolated have not been tested in serial passage and none of the implicated organisms has been recovered from animals that received Crohn disease tissue homogenates.
Congenitally athymic nude mice (nu/nu) do not develop typical granulomatous lesions because they lack T cells. Injection with agents that produce granulomas in normal mice may result in atypical lesions in nude mice (15, 16, 24) . Virus replication may be blocked by immunological reactions in normal mice, whereas it may be expressed in nu/nu mice (19, 25) .
The development of lymphoma after injection of mesenteric lymph node homogenates from patients with Crohn disease was unexpected and raises several questions. The possibility of spontaneous lymphoma is unlikely because lymphoma was produced by injecting homogenates from four patients with Crohn.disease. Cell-free filtrates of two tumors produced intraabdominal lymphoma in a second group of mice. Two of the four lymphomas developed in mice less than 6 months old, an age at which spontaneous lymphoma in nu/nu is extremely rare (26, 27) .
The development of lymphoma may be related to a virus in the lymph node homogenates of patients with Crohn disease causing transformation of lymphoid cells in nu/nu mice. It may also result from a "factor," infectious or chemical, that stimu-lates a latent murine oncogenic virus. In favor of the first possibility is the strongly positive cytoplasmic immunofluorescence of the mouse lymphoma by all Crohn disease sera and not by control sera. There are several possible explanations for induction of lymphoma in only 16% of nu/nu mice injected with Crohn disease homogenates. The "viral" titer in Crohn disease filtrates may be low. During the second passage, two of the five nu/nu mice injected with lymphoma filtrates developed lymphoma, which suggests amplification of "viral" titer. "Virus particles" may coprecipitate with organelles during homogenization and centrifugation and may not have been injected into nu/nu mice. If a virus is present in the Crohn disease filtrates that were injected into nu/nu mice, a natural killer cell response may eliminate the virus, as was demonstrated after injection of measles-and mumps-infected cell lines into nu/nu mice (28) .
Certain lymphocytes of nu/nu mice infected with Crohn disease "agent" may escape the immune mechanism and produce lymphoma. Suppression of natural killer response by irradiation or injection of anti-lymphocyte serum (29) may enhance the incidence of lymphoma after injection of Crohn disease homogenates.
The surface markers of the two lymphoid cell lines suggest that they are murine B cells and have positive surface Ig and Fc receptor without complement receptor and Thy-1.2 antigen, a T cell marker. Production of B cell lymphoma may reflect the intact B cell system of the nude mice, which could be stimulated by Crohn disease tissue homogenates. However, selective B lymphocyte tumors in conventional mice have been induced experimentally by using carcinogens or Abelson virus (30) (31) (32) (33) . Whether such a specific stimulation of B cells occurs by the putative agent related to Crohn disease is not clear.
The number of surviving mice that received control tissue homogenates was 28 as opposed to 23 for the Crohn disease group. None of the mice injected with control lymph node homogenates from patients with sarcoidosis or ulcerative colitis or with normal mesenteric nodes from patients with cholecystitis developed lymphoma. The validity of these results may be argued because of the small number of animals. However, production of lymphoma in 4 of 23 mice injected with materials from four patients with Crohn disease and the recognition of the tumor tissue by the sera from patients with Crohn disease support a direct relationship between production of murine lymphoma and Crohn disease.
Sera from patients with active Crohn disease apparently contain antibodies to a factor present in the induced lymphomas. The likely factor would be a virus or virus-related protein(s). Amplification of this agent may be unique in nu/nu mice due to its enhanced growth and expression. This putative agent related to Crohn disease has yet to be isolated and characterized.
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